HMGB1 and metastatic malignant neoplasm in the lymph nodes: Blood loss (≥ 800 ml), intraoperative transfusion, advanced T stage (T2, T3a), lymph-node metastasis, and HMGB1 high expression were significantly associated with shorter overall survival.